Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Visualizações
• 07/17/23
0
0
Embutir
administrator
Assinantes
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários